Should C-reactive protein be added to metabolic syndrome and to assessment of global cardiovascular risk?

By P. Ridker, Peter W. F. Wilson, S. Grundy. Circulation, 2004

697 citations recorded by the source corpus.

Subfields: Endocrinology, Diabetes and Metabolism, Epidemiology, Surgery

View Paper: https://www.semanticscholar.org/paper/021d6aac9350108c8e9f0d92197fe73534761bb5

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Endocrinology, Diabetes and Metabolism

1. E. Ferrannini
2. John B. Buse
3. P. Ridker
4. Peter Libby
5. S. Grundy

In Epidemiology

1. John B. Buse
2. E. Ferrannini
3. R. Kahn
4. M. Stern
5. M. Jain
6. James J. Heckman
7. B. Roberts
8. Terrie E. Moffitt

In Surgery

1. R. Kahn
2. E. Ferrannini
3. John B. Buse
4. M. Stern
5. P. Ridker
6. Peter Libby
7. L. Melvin

Citations in the corpus

• C-reactive protein and the prediction of cardiovascular events among those at intermediate risk: moving an inflammatory hypothesis toward consensus. (2007, neutral): “he time has come to modify traditional algorithms used for i he global detection of vascular risk (51).”
• A gradient of childhood self-control predicts health, wealth, and public safety (2011, background): “Sociologists find that low self-control predicts unemployment (12) and name self-control as a central causal variable in crime theory (13), providing evidence that low self-control characterizes lawbreakers (14, 15).”
• Female and male antisocial trajectories: From childhood origins to adult outcomes (2008, background): “0 mg/l were considered at high risk (Ridker et al., 2004).”
• The metabolic syndrome: time for a critical appraisal (2005, positive): “There is also an association between other markers of inflammation and insulin resistance/hyperinsulinaemia [70, 72], as well as inflammation and obesity [77–79], leading some investigators to conclude that inflammation is integrally related to the components of the metabolic syndrome [76, 77, 80].”
• Anti-Inflammatory Effects of Statins: Clinical Evidence and Basic Mechanisms (2005, background): “As described earlier, individuals with elevated levels of CRP (>3 mg per litre) are at increased risk for first, as well as recurrent, cardiovascular events independent of lipid levels and disease severity as determined by global risk-assessment tools such as the Framingham Risk Scor”